BALTIMORE – Digital therapeutic company Welldoc has appointed Daniel Garrett to its board of directors. Garrett was formerly a partner at PricewaterhouseCooper. “While I’ve seen many digital health companies come and go during my years with PwC, Welldoc has remained steadfast and vigilant in its pursuit of developing innovative technologies that are clinically proven to transform the lives of patients living with chronic diseases,” said Garrett in a statement. Welldoc provides digital therapeutics for people with chronic diseases.
You are here: / / Garrett joins Welldoc board